Telesis Bio (TBIO) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-6.19M
Depreciation and amortization	264K
Non-cash, stock based compensation	111K
Provision for losses on doubtful accounts	72K
Provision for losses on inventory obsolescence
Preferred stock revaluation
Accounts receivable	12K
Inventories	14K
Prepaid expenses and other current assets	280K
Accounts payable	2.49M
Accrued liabilities
Other long term liabilities
Long term deferred income taxes	0
Net cash flows provided by (used in) operating activities	-3.57M
Purchase of property and equipment	-19K
Change in other assets	-27K
Net cash flows used in investing activities	1.01M
Principal payments on capital lease obligations	-2K
Issuance of common stock	468K
Principal payment on note payable	-550K
Net cash flows provided by (used in) financing activities	2.2M
EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGES ON CASH	0
NET CHANGE IN CASH AND CASH EQUIVALENTS	-373K
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	444K
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	71K
Interest	0
Income taxes, net
Acquisition of equipment through capital leases
Dividends payable on preferred stock

Entities mentioned with TBIO

View All Entities